All Posts By

Smartkarma Daily Briefs

Daily Brief China: Tencent, CK Hutchison Holdings, BYD, Xiangtan Electric Manufacturing Co,Ltd., AIA Group Ltd, Hang Seng Index, Baidu, Silergy Corp, Salter Brothers Emerging Cos L, Kanzhun and more

By | China, Daily Briefs

In today’s briefing:

  • Asian Equities: Valuation Mean Reversion – The Winners and Losers
  • CK Hutch (1 HK): Still Trading Cheap
  • BYD (1211 HK) 2024 Result Preview: Expanding in Domestic Market and 19% Upside Left
  • CSI 1000 Index Rebalance Preview: US$3.7bn Trade; Adds Outperform as ETFs Face Redemptions
  • AIA Group (1299 HK) Results Day: Expected Price Swings and Dividend Boost
  • HSI Outpaces SPX — Structural Break or Head Fake? Strategies for Hedging
  • [Baidu, Inc. (BIDU US, SELL, TP US$92.5) TP Change]: What Can Change BIDU from SELL to a BUY?
  • Silergy (6147.TT): 1Q25 Outlook Sales: Down QoQ but up QoQ. 2025 Outlook Sales: Up 20-30% YoY.
  • Asia Real Estate Tracker (13-Mar-2025): Mitsui AM buys 50% of Tokyo Data Centre for $120M.
  • [Kanzhun (BZ US, BUY, TP US$20) TP Change]: Catalysts from Robust Post CNY Hiring and AI Initiative


Asian Equities: Valuation Mean Reversion – The Winners and Losers

By Manishi Raychaudhuri

  • Valuations across Asia are mean reverting – expensive markets derating and the cheap ones rerating. We think this is likely to continue somewhat longer.
  • We think HK/China could rerate more; India and Taiwan could derate slightly further. India looks interesting. Valuation range has structurally shifted upwards. But another 5-10% relative valuation correction is warranted.
  • Principal stock choices in HK/China, Korea and India pertain to themes of domestic consumption, AI resilience and unloved sectors. Some of the companies have mitigating strategies for the tariff war.

CK Hutch (1 HK): Still Trading Cheap

By David Blennerhassett

  • To avoid a political landmine, on the 4th March CK Hutchison Holdings (1 HK)  announced a deal with Blackrock to offload its entire port ops, including the contentious Panama ports.
  • It’s an astute deal selling to a buyer, ostensibly backed by the Trump administration, at the top of the market, knowing global trade could fall under a new tariff regime.
  • The risk to the transaction is one of timing. US/Panama approvals are a shoo-in. But it’s a complex deal, which will take time to work through the system.

BYD (1211 HK) 2024 Result Preview: Expanding in Domestic Market and 19% Upside Left

By Ming Lu

  • BYD will release its 2025 annual results on March 24.
  • The stock price has risen by 38% since our last buy rating on January 6.
  • However, we believe there is still an upside of 19% for the next twelve months.

CSI 1000 Index Rebalance Preview: US$3.7bn Trade; Adds Outperform as ETFs Face Redemptions

By Brian Freitas

  • With over 85% of the review period now complete, we forecast 100 changes (the maximum permitted) for the CSI 1000 Index at the close on 13 June.
  • We estimate a one-way turnover of 11% at the rebalance resulting in a round-trip trade of CNY26.9bn (US$3.7bn). The Industrials sector could gain the most index spots.
  • The forecast adds have outperformed the forecast deletes this calendar year. Part of that can be attributed to the outflows from ETFs tracking the CSI1000 Index.

AIA Group (1299 HK) Results Day: Expected Price Swings and Dividend Boost

By Gaudenz Schneider

  • AIA Group (1299 HK) is set to announce its 2024 Annual Results on 14 March 2025, 09:00 am HK Time.
  • AIA Group (1299 HK) has historically experienced volatile trading during results days, with a median move of +/- 4.2%, considerably higher than typical daily movements. 
  • AIA Group Ltd (1299 HK) will announce its final dividend. With a history of increases, a divided raise can be expected.

HSI Outpaces SPX — Structural Break or Head Fake? Strategies for Hedging

By John Ley

  • HSI has surged past SPX, but past instances of strong outperformance have often preceded reversals. We examine key historical trends.
  • The YTD divergence between HSI and SPX calls into question whether this is another temporary rally or the start of a new trend.
  • We highlight some key hedging strategies to manage risk in this evolving market dynamic.

[Baidu, Inc. (BIDU US, SELL, TP US$92.5) TP Change]: What Can Change BIDU from SELL to a BUY?

By Ying Pan

  • We conducted a drill exercise in which BIDU’s search revenue will shrink to 1/3 of its size while its AI cloud
  • Our key concern is margin compression as search’s high margin as a result of browser infrastructure and monopolistic status aren’t repeatable in AI;
  • We raise the TP from US$80.0 to US$92.5 and maintain SELL.

Silergy (6147.TT): 1Q25 Outlook Sales: Down QoQ but up QoQ. 2025 Outlook Sales: Up 20-30% YoY.

By Patrick Liao

  • 2025 outlook Sales: up 20-30% YoY. More certain on China demand recovery. Gradually enters Mass-Production (MP) for Gen 3/4 products. Main growth drivers are consumer and Electric Vehicle.  
  • Silergy targets for auto sales contributed to reach 15% in 2025.  
  • Will witness a rebound in 2Q25 for computing and Consumer and auto will also grow QoQ given resumption for production in China.  

Asia Real Estate Tracker (13-Mar-2025): Mitsui AM buys 50% of Tokyo Data Centre for $120M.

By Asia Real Estate Tracker

  • Mitsui AM invests $120M in acquiring 50% stake in Greater Tokyo Data Centre, expanding their presence in the region.
  • Star Entertainment secures $590M refinancing from Salter Brothers in Australia, providing capital for future growth and development.
  • Panel discussion highlights how Australia’s evolving society is shifting focus of Build-to-Rent sector from macro to micro level.

[Kanzhun (BZ US, BUY, TP US$20) TP Change]: Catalysts from Robust Post CNY Hiring and AI Initiative

By Eric Wen

  • Kanzhun Limited (BZ) reported 4Q24 revenue in-line with consensus, and non-GAAP net income beat by 4.0%, thanks to efficient user acquisition, 
  • Although t`he cash billing collected is weak in 4Q24, post CNY job posting number is a bright spot, leading us to tentatively raise 2025 topline by 2.5%;
  • We rise the TP to US$20 and maintain BUY rating to factor in the early trend in hiring recovery and AI initiatives.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Recruit Holdings, CK Hutchison Holdings, Xiangtan Electric Manufacturing Co,Ltd., Korea Stock Exchange KOSPI 200, LS Corp, Capita PLC, Melrose Industries , GlobalData , Ads-Tec Energy , Mytilineos Holdings Sa and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Recruit Holdings Placement – Relatively Small US$520m Deal but Momentum Is Weak
  • CK Hutch (1 HK): Still Trading Cheap
  • CSI 1000 Index Rebalance Preview: US$3.7bn Trade; Adds Outperform as ETFs Face Redemptions
  • Digging Into the Early Full Rollout of NPS’s Reference Portfolio Play
  • Hoban Group Purchases LS Corp Shares – Is This a Hanjin Kal 2.0?
  • Capita Group — AI driving transformation in 2025
  • Melrose Industries — The horizon remains positive
  • GlobalData — Connected intelligence platform
  • ADS-TEC Energy — Positive progress in 2024
  • Metlen Energy & Metals — FY24 results to maintain €1bn+/year EBITDA


Recruit Holdings Placement – Relatively Small US$520m Deal but Momentum Is Weak

By Sumeet Singh

  • An undisclosed seller is looking to raise around US$520m via selling 0.5% of its stake in Recruit Holdings (6098 JP) .
  • We have covered a number of placements in the stock over the past few years, most of which have ended up doing well.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

CK Hutch (1 HK): Still Trading Cheap

By David Blennerhassett

  • To avoid a political landmine, on the 4th March CK Hutchison Holdings (1 HK)  announced a deal with Blackrock to offload its entire port ops, including the contentious Panama ports.
  • It’s an astute deal selling to a buyer, ostensibly backed by the Trump administration, at the top of the market, knowing global trade could fall under a new tariff regime.
  • The risk to the transaction is one of timing. US/Panama approvals are a shoo-in. But it’s a complex deal, which will take time to work through the system.

CSI 1000 Index Rebalance Preview: US$3.7bn Trade; Adds Outperform as ETFs Face Redemptions

By Brian Freitas

  • With over 85% of the review period now complete, we forecast 100 changes (the maximum permitted) for the CSI 1000 Index at the close on 13 June.
  • We estimate a one-way turnover of 11% at the rebalance resulting in a round-trip trade of CNY26.9bn (US$3.7bn). The Industrials sector could gain the most index spots.
  • The forecast adds have outperformed the forecast deletes this calendar year. Part of that can be attributed to the outflows from ETFs tracking the CSI1000 Index.

Digging Into the Early Full Rollout of NPS’s Reference Portfolio Play

By Sanghyun Park

  • The street suspects NPS is fast-tracking its reference portfolio in local equities, not just rebalancing to cover last year’s underweight in its Q1 2025 adjustment.
  • The passive-to-active shift is on—starting with enhanced passive, then an early ramp into event-driven and high-conviction active plays.
  • We traders should expect outsized swings in leaders and restructuring plays as NPS flows amplify moves.

Hoban Group Purchases LS Corp Shares – Is This a Hanjin Kal 2.0?

By Douglas Kim

  • In this insight, we discuss a new catalyst on the share price of LS Corp (006260 KS) which is the purchase of its shares by the Hoban Group. 
  • Hoban Group has recently purchased shares of LS Corp. Although the exact percentage of shares has yet to be made public, it is estimated to be less than 3%. 
  • LS Corp could improve shareholder returns. Plus, the ongoing litigation between Taihan Electric Wire and LS Cable may be the real reason why Hoban decided to invest in LS Corp. 

Capita Group — AI driving transformation in 2025

By Edison Investment Research

FY24 was a transformative year for Capita Group. With a new CEO and CFO, the company made good progress on its ‘Better Capita’ strategy. Capita is at the forefront of the significant opportunity arising from leveraging modern technologies, such as AI, to improve operational efficiencies, scalability and profits. During FY24 Capita began leveraging leading hyperscalers within AI, enabling it to lead the shift to a ‘service-as-software’ business model, redefining the support services industry. Capita also delivered £140m of annualised cost savings through its accelerated cost reduction strategy in 2024, to create better efficiencies across the wider group. Management confirmed in December 2024 that it had increased its total cost reduction target to £250m by end-December 2025, up from £160m by end-June 2025 previously, primarily driven by increases in the use of AI and generative AI, fundamentally improving its operating model.


Melrose Industries — The horizon remains positive

By Edison Investment Research

Melrose continues to build on its track record of delivering to expectations. Indeed the Engines division has achieved FY25 target returns a year early. This provides confidence in management’s new medium-term guidance (to FY29): a minimum EPS CAGR of 20% and acceleration to £600m of annual free cash flow, benefiting from the maturing of the risk and revenue sharing partnerships (RRSPs). With further potential from additional military spend not factored in, the shares offer interesting value.


GlobalData — Connected intelligence platform

By Edison Investment Research

GlobalData’s results were as flagged, with the first year of its transformation plan setting the foundations for management’s goal of £500m of annualised revenue by end 2026. To get there it has to accelerate from its underlying 4% revenue growth rate to at least high single digits. It plans to do this by leveraging its platform with ever-greater customer focus and increasing use of AI, already well embedded, alongside continuing M&A. The Inflexion deal has given the financial resource, with a year-end net cash balance of £10m. The dividend has been rebased to reflect the transformation plan priorities, with a further £50m share buyback announced for the current year. GlobalData is planning to transition across to LSE’s Main Market, allowing investment from a broader cohort of potential shareholders.


ADS-TEC Energy — Positive progress in 2024

By Edison Investment Research

ADS-TEC reported record revenue, albeit below previous guidance, despite 2024 being a more challenging period for EVs and associated infrastructure-related companies and some revenue deferrals into FY25. Strategic progress has laid the foundation for some potentially significant roll-out programmes. In addition, the company has announced plans to develop longer-term, more stable business revenues through value-added services, aimed at helping customers operate their infrastructure and maximise commercial potential. We will update our forecasts on publication of the detailed FY24 results.


Metlen Energy & Metals — FY24 results to maintain €1bn+/year EBITDA

By Edison Investment Research

Metlen’s FY24 results are scheduled for release on 20 February. We are expecting the conference call discussion to focus on the medium-term growth outlook, given the company’s recent announcement of an additional €300m investment in bauxite, alumina and gallium production, as well as its progress towards a listing on the London Stock Exchange (expected in H225).


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Tencent, Satyam Computer Services, Intel Corp, Samsung Electronics, Alphabet , Hang Seng Index, Baidu, Taiwan Semiconductor (TSMC), Silergy Corp and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Asian Equities: Valuation Mean Reversion – The Winners and Losers
  • The Satyam Scandal: Inside India’s Enron
  • Intel Finally Gets A New CEO: Lip-Bu Tan. Now What?
  • Intel: A Better CEO that Understand that Intel Should Fix Its Own Problems, Not Compete with TSMC
  • What We Need to Know About the Korean Commercial Act Amendment Right Now
  • Alphabet President and CIO: Advancing AI, Quantum Computing, and Self-Driving Cars
  • HSI Outpaces SPX — Structural Break or Head Fake? Strategies for Hedging
  • [Baidu, Inc. (BIDU US, SELL, TP US$92.5) TP Change]: What Can Change BIDU from SELL to a BUY?
  • Tech Supply Chain Tracker (14-Mar-2025): AI server BBU, Taiwan players, 2025.
  • Silergy (6147.TT): 1Q25 Outlook Sales: Down QoQ but up QoQ. 2025 Outlook Sales: Up 20-30% YoY.


Asian Equities: Valuation Mean Reversion – The Winners and Losers

By Manishi Raychaudhuri

  • Valuations across Asia are mean reverting – expensive markets derating and the cheap ones rerating. We think this is likely to continue somewhat longer.
  • We think HK/China could rerate more; India and Taiwan could derate slightly further. India looks interesting. Valuation range has structurally shifted upwards. But another 5-10% relative valuation correction is warranted.
  • Principal stock choices in HK/China, Korea and India pertain to themes of domestic consumption, AI resilience and unloved sectors. Some of the companies have mitigating strategies for the tariff war.

The Satyam Scandal: Inside India’s Enron

By Mark Jolley

  • Satyam’s chairman and founder confessed in January 2009 to misappropriating about $1.5 billion of company funds
  • Scandal shook confidence in Indian corporate governance and the country’s IT services industry
  • Transparently.ai’s AI tools detected accounting red flags in Satyam as early as 1998

Intel Finally Gets A New CEO: Lip-Bu Tan. Now What?

By William Keating

  • Lip-Bu Tan, former CEO of Cadence and founding partner at Walden Catalyst Ventures, will become Intel’s ninth CEO effective March 18
  • Mr. Tan is an extremely impressive technology leader, speaker, & influencer with many and varied interests. He is an excellent choice for the most important CEO role in Intel’s history
  • Press releases seem to emphasise Products over Foundry but any decision in this regard will take time so it doesn’t appear that Mr. Tan is simply following the board’s orders.

Intel: A Better CEO that Understand that Intel Should Fix Its Own Problems, Not Compete with TSMC

By Nicolas Baratte

  • The return of Mr. Tan as CEO suggests that spinning off or selling  Intel Foundry will accelerate, Intel’s focus should improve.
  • It probably also means scaling down considerably Intel manufacturing plans and outsourcing more to TSMC. If you can’t beat them, join them.
  • Now is not a good time to buy Semiconductor stocks. It will take a couple of years to fix Intel’s problems. TSMC will benefit.

What We Need to Know About the Korean Commercial Act Amendment Right Now

By Sanghyun Park

  • Lee Bok-hyun, FSS Chairman, unexpectedly reversed his stance and now opposes Choi’s veto on the amendment, pushing for shareholder protection and adjustments in subordinate regs instead.
  • From a short-term trading angle, traders will focus on stocks with high volatility potential related to auditor appointments rather than the extension of directors’ fiduciary duties to shareholders.
  • Large-Cap banks and non-bank stocks, with low controlling stakes and high foreign ownership, are likely to see significant short-term trading impact.

Alphabet President and CIO: Advancing AI, Quantum Computing, and Self-Driving Cars

By In Good Company with Nicolai Tangen

  • Google’s full stack approach to AI, led by Nobel Prize winner Demis Asabas, includes talent, models, platforms, and chips
  • Generative AI is being used to enhance search and enterprise solutions, providing monetization opportunities
  • Google prioritizes quality and safety in AI development, ensuring no margin for error in critical situations like medical queries

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


HSI Outpaces SPX — Structural Break or Head Fake? Strategies for Hedging

By John Ley

  • HSI has surged past SPX, but past instances of strong outperformance have often preceded reversals. We examine key historical trends.
  • The YTD divergence between HSI and SPX calls into question whether this is another temporary rally or the start of a new trend.
  • We highlight some key hedging strategies to manage risk in this evolving market dynamic.

[Baidu, Inc. (BIDU US, SELL, TP US$92.5) TP Change]: What Can Change BIDU from SELL to a BUY?

By Ying Pan

  • We conducted a drill exercise in which BIDU’s search revenue will shrink to 1/3 of its size while its AI cloud
  • Our key concern is margin compression as search’s high margin as a result of browser infrastructure and monopolistic status aren’t repeatable in AI;
  • We raise the TP from US$80.0 to US$92.5 and maintain SELL.

Tech Supply Chain Tracker (14-Mar-2025): AI server BBU, Taiwan players, 2025.

By Tech Supply Chain Tracker

  • By 2025, AI server to be developed by Intel for BBU and Taiwanese players, aiming to enhance performance and innovation in the market.
  • Nvidia visits Samsung amidst supply uncertainty of HBM3E, highlighting the importance of partner collaboration in the semiconductor industry.
  • Intel’s unveiling of Panther Lake, powered by 18A core ultra chips, signals a new era of technology advancement in the company’s product lineup.

Silergy (6147.TT): 1Q25 Outlook Sales: Down QoQ but up QoQ. 2025 Outlook Sales: Up 20-30% YoY.

By Patrick Liao

  • 2025 outlook Sales: up 20-30% YoY. More certain on China demand recovery. Gradually enters Mass-Production (MP) for Gen 3/4 products. Main growth drivers are consumer and Electric Vehicle.  
  • Silergy targets for auto sales contributed to reach 15% in 2025.  
  • Will witness a rebound in 2Q25 for computing and Consumer and auto will also grow QoQ given resumption for production in China.  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Recruit Holdings, CK Hutchison Holdings, Xiangtan Electric Manufacturing Co,Ltd., Korea Stock Exchange KOSPI 200, LS Corp, Capita PLC, Melrose Industries , GlobalData , Ads-Tec Energy , Mytilineos Holdings Sa and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Recruit Holdings Placement – Relatively Small US$520m Deal but Momentum Is Weak
  • CK Hutch (1 HK): Still Trading Cheap
  • CSI 1000 Index Rebalance Preview: US$3.7bn Trade; Adds Outperform as ETFs Face Redemptions
  • Digging Into the Early Full Rollout of NPS’s Reference Portfolio Play
  • Hoban Group Purchases LS Corp Shares – Is This a Hanjin Kal 2.0?
  • Capita Group — AI driving transformation in 2025
  • Melrose Industries — The horizon remains positive
  • GlobalData — Connected intelligence platform
  • ADS-TEC Energy — Positive progress in 2024
  • Metlen Energy & Metals — FY24 results to maintain €1bn+/year EBITDA


Recruit Holdings Placement – Relatively Small US$520m Deal but Momentum Is Weak

By Sumeet Singh

  • An undisclosed seller is looking to raise around US$520m via selling 0.5% of its stake in Recruit Holdings (6098 JP) .
  • We have covered a number of placements in the stock over the past few years, most of which have ended up doing well.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

CK Hutch (1 HK): Still Trading Cheap

By David Blennerhassett

  • To avoid a political landmine, on the 4th March CK Hutchison Holdings (1 HK)  announced a deal with Blackrock to offload its entire port ops, including the contentious Panama ports.
  • It’s an astute deal selling to a buyer, ostensibly backed by the Trump administration, at the top of the market, knowing global trade could fall under a new tariff regime.
  • The risk to the transaction is one of timing. US/Panama approvals are a shoo-in. But it’s a complex deal, which will take time to work through the system.

CSI 1000 Index Rebalance Preview: US$3.7bn Trade; Adds Outperform as ETFs Face Redemptions

By Brian Freitas

  • With over 85% of the review period now complete, we forecast 100 changes (the maximum permitted) for the CSI 1000 Index at the close on 13 June.
  • We estimate a one-way turnover of 11% at the rebalance resulting in a round-trip trade of CNY26.9bn (US$3.7bn). The Industrials sector could gain the most index spots.
  • The forecast adds have outperformed the forecast deletes this calendar year. Part of that can be attributed to the outflows from ETFs tracking the CSI1000 Index.

Digging Into the Early Full Rollout of NPS’s Reference Portfolio Play

By Sanghyun Park

  • The street suspects NPS is fast-tracking its reference portfolio in local equities, not just rebalancing to cover last year’s underweight in its Q1 2025 adjustment.
  • The passive-to-active shift is on—starting with enhanced passive, then an early ramp into event-driven and high-conviction active plays.
  • We traders should expect outsized swings in leaders and restructuring plays as NPS flows amplify moves.

Hoban Group Purchases LS Corp Shares – Is This a Hanjin Kal 2.0?

By Douglas Kim

  • In this insight, we discuss a new catalyst on the share price of LS Corp (006260 KS) which is the purchase of its shares by the Hoban Group. 
  • Hoban Group has recently purchased shares of LS Corp. Although the exact percentage of shares has yet to be made public, it is estimated to be less than 3%. 
  • LS Corp could improve shareholder returns. Plus, the ongoing litigation between Taihan Electric Wire and LS Cable may be the real reason why Hoban decided to invest in LS Corp. 

Capita Group — AI driving transformation in 2025

By Edison Investment Research

FY24 was a transformative year for Capita Group. With a new CEO and CFO, the company made good progress on its ‘Better Capita’ strategy. Capita is at the forefront of the significant opportunity arising from leveraging modern technologies, such as AI, to improve operational efficiencies, scalability and profits. During FY24 Capita began leveraging leading hyperscalers within AI, enabling it to lead the shift to a ‘service-as-software’ business model, redefining the support services industry. Capita also delivered £140m of annualised cost savings through its accelerated cost reduction strategy in 2024, to create better efficiencies across the wider group. Management confirmed in December 2024 that it had increased its total cost reduction target to £250m by end-December 2025, up from £160m by end-June 2025 previously, primarily driven by increases in the use of AI and generative AI, fundamentally improving its operating model.


Melrose Industries — The horizon remains positive

By Edison Investment Research

Melrose continues to build on its track record of delivering to expectations. Indeed the Engines division has achieved FY25 target returns a year early. This provides confidence in management’s new medium-term guidance (to FY29): a minimum EPS CAGR of 20% and acceleration to £600m of annual free cash flow, benefiting from the maturing of the risk and revenue sharing partnerships (RRSPs). With further potential from additional military spend not factored in, the shares offer interesting value.


GlobalData — Connected intelligence platform

By Edison Investment Research

GlobalData’s results were as flagged, with the first year of its transformation plan setting the foundations for management’s goal of £500m of annualised revenue by end 2026. To get there it has to accelerate from its underlying 4% revenue growth rate to at least high single digits. It plans to do this by leveraging its platform with ever-greater customer focus and increasing use of AI, already well embedded, alongside continuing M&A. The Inflexion deal has given the financial resource, with a year-end net cash balance of £10m. The dividend has been rebased to reflect the transformation plan priorities, with a further £50m share buyback announced for the current year. GlobalData is planning to transition across to LSE’s Main Market, allowing investment from a broader cohort of potential shareholders.


ADS-TEC Energy — Positive progress in 2024

By Edison Investment Research

ADS-TEC reported record revenue, albeit below previous guidance, despite 2024 being a more challenging period for EVs and associated infrastructure-related companies and some revenue deferrals into FY25. Strategic progress has laid the foundation for some potentially significant roll-out programmes. In addition, the company has announced plans to develop longer-term, more stable business revenues through value-added services, aimed at helping customers operate their infrastructure and maximise commercial potential. We will update our forecasts on publication of the detailed FY24 results.


Metlen Energy & Metals — FY24 results to maintain €1bn+/year EBITDA

By Edison Investment Research

Metlen’s FY24 results are scheduled for release on 20 February. We are expecting the conference call discussion to focus on the medium-term growth outlook, given the company’s recent announcement of an additional €300m investment in bauxite, alumina and gallium production, as well as its progress towards a listing on the London Stock Exchange (expected in H225).


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: Rio Tinto Ltd, Crude Oil, Gujarat Fluorochemicals, ArcelorMittal , SGX Rubber Future TSR20, Cleveland-Cliffs Inc , Copper, Koninklijke Vopak Nv, Nicola Mining, Oneok Inc and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Rio Tinto (RIO LN/RIO AU): Thinking About Unification
  • The Drill – The gameplan for peace in Ukraine
  • The Beat Ideas: Gujarat Flurochemicals 2.0: From Fluoropolymer Powerhouse to Battery Technology
  • ArcelorMittal (MT US) Is Deep Discount to Indian Mills Warranted?
  • EUDR: EC Mandates Due Diligence For All In Rubber Supply Chain Except SMEs
  • Cleveland-Cliffs: Ramping Up Automotive Sector Engagement To Catalyze Top-Line Growth!
  • Post Results FY24: Mine-By-Mine Plan Production + Commentary on Copper From Global Listed Companies
  • What’s New(s) in Amsterdam – 13 March 2025 (AMG Critical Materials | Vopak | Triodos Bank)
  • NIM: Final Permit for Bulk Sample at Dominion Creek Received
  • Will Oneok’s Mexico LNG Move Transform Their Future?


Rio Tinto (RIO LN/RIO AU): Thinking About Unification

By Arun George

  • Rio Tinto Ltd (RIO AU) shareholders will vote on Palliser’s AGM resolution to conduct an independent review on whether the potential unification is in the best interests of shareholders. 
  • Palliser and the Board’s arguments for and against unification focus on five factors: tax costs, post-unification share price, lack of scrip M&A, wastage of franking credits, and shareholder support.
  • A Grant Thornton report supports unification. The board’s case is strong primarily on tax costs, while Palliser’s case is strong on post-unification share price, M&A, and franking credits.

The Drill – The gameplan for peace in Ukraine

By Andreas Steno

  • Hello, and welcome back to our weekly editorial on commodities and geopolitics.
  • Trump is keeping us busy yet again, threatening to impose another 25 percentage points (which was pulled back a couple of hours later, as usual) on top of the steel and aluminum tariffs, targeting the Canadian car industry at the same time.
  • By now, it’s very clear that his main agenda is to move jobs and factories to the U.S. by limiting imports—but the question remains: will he actually follow through?

The Beat Ideas: Gujarat Flurochemicals 2.0: From Fluoropolymer Powerhouse to Battery Technology

By Sudarshan Bhandari

  • GFL is executing a INR 6,000 crore capex plan through FY28 to expand into battery materials, fluorospecialties etc. with commercial production of Battery Chemicals expected to start in Q4 FY25. 
  • This marks a strategic shift from a cyclical chemicals business to a high-margin, clean energy materials play positioning GFL at the core of the EV value chain as China+1 sourcing.
  • Company is becoming a structural clean-tech growth story. The business could double its revenue base and become global EV materials supplier over the next 3-4 years.

ArcelorMittal (MT US) Is Deep Discount to Indian Mills Warranted?

By Rahul Jain


EUDR: EC Mandates Due Diligence For All In Rubber Supply Chain Except SMEs

By Vinod Nedumudy

  •  EC publishes 11 commodities’ scenarios including rubber  
  • Non-SME operators, dealers tasked with due diligence onus  
  • German Rubber Association criticism fails to make impact  

Cleveland-Cliffs: Ramping Up Automotive Sector Engagement To Catalyze Top-Line Growth!

By Baptista Research

  • Cleveland-Cliffs Inc.’s earnings for the fourth quarter and full year 2024 highlighted several critical facets of the company’s recent performance and its outlook.
  • The call began with the acknowledgment of substantial challenges faced during 2024, primarily driven by weak demand from key sectors, including automotive and construction, which resulted in the idling of the C6 blast furnace at the Cleveland Works plant.
  • The impact of persistently high interest rates and ongoing trade distortions due to overproduction and unfair competition from foreign steel producers also played a significant role in shaping Cleveland-Cliffs’ challenging year.

Post Results FY24: Mine-By-Mine Plan Production + Commentary on Copper From Global Listed Companies

By Sameer Taneja

  • After analyzing their annual results, presentations, and conference call transcripts, we summarize the supply mine-by-mine and market commentary gathered from twelve major listed copper producers (40% of global production).
  • Copper supply growth is expected to be 3% YoY 2025e, resulting in a deficit of 250,000 tons (>1 million tons in 2029), while inventories currently cover a week’s global demand. 
  • With the cost curve at the last decile around $4.5$/lb, the copper price is supported greatly despite the system’s high inventories. 

What’s New(s) in Amsterdam – 13 March 2025 (AMG Critical Materials | Vopak | Triodos Bank)

By The IDEA!

  • AMG Critical Materials | completes repurchase of 40% interest in Graphit Kropfmühl AMG completed the repurchase of a 40% ownership interest in Graphit Kropfmühl and has become the sole owner again of this company.
  • Ten years ago, on March 2015, it sold a 40% equity interest in this leading global supplier of high-purity natural graphite to Alterna Capital Partners.
  • Comment | In 2012 AMG became the sole owner of GK, a vertically integrated high purity natural graphite business, with mines in Europe, Asia and Africa. 

NIM: Final Permit for Bulk Sample at Dominion Creek Received

By Atrium Research

  • Nicola announced that it received the final permit for the 10,000t bulk sample at the Dominion Creek Mineral Project.
  • The bulk sample will be processed at Nicola’s Merritt Milling Facility providing a potential third source of ore to the mill as early as Q2/25.
  • NIM announced the closing of its non-brokered private placement.

Will Oneok’s Mexico LNG Move Transform Their Future?

By Baptista Research

  • ONEOK’s Q4 2024 earnings report indicates notable strategic and financial developments over the past year.
  • The company reported higher earnings for both the quarter and the full year 2024, with significant contributions from strategic acquisitions and volume growth.
  • ONEOK’s financial prospects for 2025 are positive, with an expected earnings growth driven by expanded operations and infrastructure projects.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: AIA Group Ltd, Seoul Guarantee Insurance, Salter Brothers Emerging Cos L, Seazen (Formerly Future Land), INVESCO Asia Trust PLC, IP Group PLC, Custodian REIT, Metlife Inc, Lancashire Holdings and more

By | Daily Briefs, Financials

In today’s briefing:

  • AIA Group (1299 HK) Results Day: Expected Price Swings and Dividend Boost
  • Seoul Guarantee Insurance IPO Trading – KDIC Stake Overhang Remains, Yield Might Help
  • Asia Real Estate Tracker (13-Mar-2025): Mitsui AM buys 50% of Tokyo Data Centre for $120M.
  • Lucror Analytics – Morning Views Asia
  • Invesco Asia Trust — A patient Asian champion
  • IP Group — Examining Istesso’s Phase IIb trial results
  • Custodian Property Income REIT — Momentum building in Q325
  • MetLife Inc.: The Retirement & Income Solutions (RIS) Growth & Key Growth Levers!
  • Foxtons Group — Strong results; expect growth update at Q2 CMD
  • Lancashire Holdings — Substantial shareholder distributions


AIA Group (1299 HK) Results Day: Expected Price Swings and Dividend Boost

By Gaudenz Schneider

  • AIA Group (1299 HK) is set to announce its 2024 Annual Results on 14 March 2025, 09:00 am HK Time.
  • AIA Group (1299 HK) has historically experienced volatile trading during results days, with a median move of +/- 4.2%, considerably higher than typical daily movements. 
  • AIA Group Ltd (1299 HK) will announce its final dividend. With a history of increases, a divided raise can be expected.

Seoul Guarantee Insurance IPO Trading – KDIC Stake Overhang Remains, Yield Might Help

By Sumeet Singh

  • Seoul Guarantee Insurance (031210 KS) raised around US$125m in its Korean IPO. 
  • Seoul Guarantee Insurance (SGI) is a guarantee insurance firm operating predominantly in Korea.
  • We have looked at the firm’s past performance and discussed our thoughts on valuation. In this note, we talk about the trading dynamics.

Asia Real Estate Tracker (13-Mar-2025): Mitsui AM buys 50% of Tokyo Data Centre for $120M.

By Asia Real Estate Tracker

  • Mitsui AM invests $120M in acquiring 50% stake in Greater Tokyo Data Centre, expanding their presence in the region.
  • Star Entertainment secures $590M refinancing from Salter Brothers in Australia, providing capital for future growth and development.
  • Panel discussion highlights how Australia’s evolving society is shifting focus of Build-to-Rent sector from macro to micro level.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Seazen Group, Adani Ports, Cikarang Listrindo, Vedanta Resources
  • In the US, the February CPI came in below estimates at 0.2% m-o-m (0.3% e / 0.5% p) and 2.8% y-o-y (2.9% e / 3.0% p). Core CPI (excluding food and energy) eased to 0.2% m-o-m (0.3% e / 0.4% p) and 3.1% y-o-y (3.2% e / 3.3% p).
  • US Treasuries ended the day lower, as an initial rally following the lower-than-expected CPI inflation numbers was quickly reversed amid concerns over the escalating trade war and its impact on future inflation.

Invesco Asia Trust — A patient Asian champion

By Edison Investment Research

Invesco Asia Trust (IAT) delivered a 12.4% NAV total return (TR) over the 12 months to end-December 2024, bolstered by the stock market rally in China and Hong Kong (to which IAT’s managers patiently maintained an overweight exposure) on the back of stimulus measures announced by the authorities in September 2024. While IAT’s return is somewhat behind the 14.0% posted by its benchmark, IAT’s share price total return of 15.8% was ahead of it, and the trust maintains a strong mid- and long-term track record of outperforming the market and its peer average. IAT remains positioned to benefit from the consumption growth story of the region via a combination of internet companies, consumer-related businesses (including e-commerce) and financials stocks, among others. The managers also see opportunities across tech and manufacturing, even if they are now cautiously underweight Taiwan on valuation grounds. Finally, their below-benchmark position in Indian equities (which also command high valuations relative to the broader region) is coupled with an overweight exposure to Indonesia, where the managers see an attractive combination of growth prospects and undemanding valuations.


IP Group — Examining Istesso’s Phase IIb trial results

By Edison Investment Research

Istesso, IP Group’s largest private life sciences holding (c 11% of end-June 2024 portfolio value), has announced the results of its Phase IIb clinical trial of leramistat in rheumatoid arthritis (RA). Leramistat demonstrated a statistically significant reduction in bone erosion, the key secondary endpoint, as well as improvements in disability and fatigue. As a result, Istesso plans to evaluate the drug’s potential to promote adaptive tissue repair in RA in combination with existing disease-modifying anti-rheumatic drugs (DMARDs), as well as for other chronic diseases. It highlighted that it is sufficiently funded to conduct these studies. That said, the study failed to meet its primary endpoint of improvements in ACR20 response versus placebo. IP Group will provide an update on Istesso and its (possibly reduced) valuation upon releasing its FY24 results in March.


Custodian Property Income REIT — Momentum building in Q325

By Edison Investment Research

Custodian Property Income REIT (CREI) reported a 2.5% NAV total return for Q325, driven by income but with NAV also increasing. Portfolio values increased for the second consecutive quarter and, with a robust occupier market driving rent growth, the company is increasingly confident that the market is at or near an inflection point. CREI yields 7.8% and its portfolio has significant opportunities to further increase income and fully covered DPS. The prospects for capital growth also appear increasingly positive.


MetLife Inc.: The Retirement & Income Solutions (RIS) Growth & Key Growth Levers!

By Baptista Research

  • MetLife reported strong fourth quarter and full-year 2024 results, with adjusted earnings marking an increase and signaling resilience amid varied economic conditions, including fluctuating interest rates and inflation concerns.
  • This performance came amidst the conclusion of their five-year strategy, Next Horizon, from which the company exceeded all financial commitments and launched its New Frontier strategy, targeting improved growth dynamics.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Foxtons Group — Strong results; expect growth update at Q2 CMD

By Edison Investment Research

Foxtons Group’s FY24 results showed revenue and adjusted operating profit growth of c 11% and c 38%, respectively, reflecting the developing success of the company’s strategic vision. This suggests that its medium-term targets, particularly the revised adjusted operating profit target of £28m–33m, are coming increasingly into focus. We believe market share is being gained across all divisions. We maintain our estimates and our 134p per share valuation, though risks appear to be skewed to the upside if market momentum continues, which could be supported by a further easing of interest rates.


Lancashire Holdings — Substantial shareholder distributions

By Edison Investment Research

Lancashire Holdings released its FY24 results on 6 March and declared another 25c/share special dividend on top of the 75c/share declared in November 2024. This brings combined special dividend declarations since FY23 to 200c/share, which equates to 36% of NAV per share at the start of FY23. Lancashire introduced a more liberal dividend policy in FY24, which resulted in a full ordinary dividend declared for FY24 of 22.5c/share compared with 15c/share for FY23 (combined dividend yield of 15.3%). Year-end NAV/share was 612c compared with 617c in FY23 and a return on equity (RoE) of 23.4% compared with 24.7% in FY23. A pull-back in the share price on the back of the results and FY25 RoE guidance in the mid-teens gives a price to NAV of 1.22x, well below the 1.3–1.6x range before interest rates increased in 2022.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Nissan Tokyo Sales, Seven & I Holdings, BYD, SOCAR, Rakuten, Domino’s Pizza, Dentsu Inc, Cairn Homes PLC, British American Tobacco , Games Workshop Group PLC and more

By | Consumer, Daily Briefs

In today’s briefing:

  • [Activism Japan] Nissan Tokyo Sales (8291) Gets An ‘Outsourced Activist’ but the Value Prop Remains
  • Seven & I Holdings (3382 JP): Awaiting the Board’s Response as Couche-Tard Goes on a Charm Offensive
  • BYD (1211 HK) 2024 Result Preview: Expanding in Domestic Market and 19% Upside Left
  • SoCar: A Partial Tender Offer by SOQRI
  • The Big 3: Amazon’s Lead Grows as Rakuten Stumbles
  • Domino’s Pizza: Expanding Aggregator Platforms to Contribute To Top-Line Growth Significantly!
  • Dentsu Group — Mid-term management plan in place
  • Cairn Homes — Underlying demand supports confident outlook
  • British American Tobacco — Moving to a smokeless world
  • Games Workshop Group — Momentum continued into Q325


[Activism Japan] Nissan Tokyo Sales (8291) Gets An ‘Outsourced Activist’ but the Value Prop Remains

By Travis Lundy

  • On 12 March 2025, a minor Twitter account @nanahoshiuk started in January announced a website shiftnissantokyo.com where they point out the value proposition in Nissan Tokyo Sales (8291 JP)
  • The writeup is by a UK company led by a young man with an equity-investing career, some experience at an activist shop, who now runs a “Shareholder Activism Outsourcing Service.”
  • The content sounds familiar to my piece in December, has a few unpolished edges, but clearly points out the value proposition. The stock deserves a re-visit. My comments are below.

Seven & I Holdings (3382 JP): Awaiting the Board’s Response as Couche-Tard Goes on a Charm Offensive

By Arun George

  • On 13 March, Alimentation Couche-Tard (ATD CN)’s management held its first press conference in Japan since it disclosed its Seven & I Holdings (3382 JP) offer.
  • The Couche-Tard charm offensive was designed to pressure the Board to engage and facilitate a definite agreement. The press conference provided incremental new information.
  • The Board’s next move will likely provide limited due diligence, partly to avoid a protest vote at the May AGM. However, the prospect of a Board-recommended binding proposal remains low.

BYD (1211 HK) 2024 Result Preview: Expanding in Domestic Market and 19% Upside Left

By Ming Lu

  • BYD will release its 2025 annual results on March 24.
  • The stock price has risen by 38% since our last buy rating on January 6.
  • However, we believe there is still an upside of 19% for the next twelve months.

SoCar: A Partial Tender Offer by SOQRI

By Douglas Kim

  • After the market close on 13 March, it was reported that SOQRI Co will be doing a partial tender offer public offering of 171,429 common shares of Socar.
  • The tender offer period is from 14 March to 2 April. The tender offer price is 17,500 won which is a 21% premium to current price.
  • Socar’s founder Lee Jae-Woong is pushing for a tender offer to solidify the control of Socar from Lotte Rental which has recently been purchased by Affinity Equity Partners.

The Big 3: Amazon’s Lead Grows as Rakuten Stumbles

By Michael Causton

  • Amazon’s growing lead in Japan’s e-commerce market looks increasingly inexorable. 
  • While growth in Japan was slower than some other Amazon markets, it still outpaced Rakuten. LY Corp did better but partly in reaction to poor results the year before. 
  • Meanwhile, a recent survey suggests growing interest in brand-operated online stores, particularly to read more in-depth content and use brand-based points.

Domino’s Pizza: Expanding Aggregator Platforms to Contribute To Top-Line Growth Significantly!

By Baptista Research

  • Domino’s Pizza faced a mixed financial performance in the fourth quarter of 2024, with weaker-than-expected earnings leading to a stock decline, despite ongoing efforts to enhance value and operational efficiency.
  • The company’s total revenue increased by 2.9% year-over-year to $1.44 billion but fell short of the $1.48 billion analyst consensus.
  • Earnings per share rose by 9.2% to $4.89, just below Wall Street’s expectation of $4.90.

Dentsu Group — Mid-term management plan in place

By Edison Investment Research

Dentsu has published its FY24 results, which show a strong Q424 in its Japanese business, ensuring that the group effectively met November’s net revenue guidance despite continuing weakness in international trading. As a result of higher discount rates and shifts in the international risk profile, Dentsu has taken a ¥210.1bn impairment charge, split ¥153.0bn in EMEA and ¥57.1bn in the Americas. The group has also now launched its new mid-term management plan (MTMP), targeting organic revenue growth of 4% in FY27, with operating margins of 16–17% by the plan’s completion. This involves a re-evaluation of the underperforming businesses within the group and laying solid foundations on which to build.


Cairn Homes — Underlying demand supports confident outlook

By Edison Investment Research

Cairn Homes’ FY24 results were robust and it has issued even more challenging targets for FY25. The Irish housing market remains undersupplied, which bodes well for its future, supported by government policies to prioritise housing delivery. The valuation remains attractive, with the stock trading on a price-to-earnings (P/E) ratio of under 11x and yielding nearly 5%.


British American Tobacco — Moving to a smokeless world

By Edison Investment Research

British American Tobacco’s (BAT’s) strategy is to become a predominantly smokeless business, generating more than 50% of revenue (FY24: 17.5%) from smokeless products by FY35. The industry backdrop is favourable, with higher revenue growth expected as consumers move to new reduced-risk products. Having transformed its capabilities through scientific research, customer engagement and product innovation, management believes focused investment should enable BAT to continue capturing the enhanced growth opportunity with better returns. BAT is confident of higher profit growth in FY25 before hitting its full stride of 4–6% pa sustainable growth from FY26, comparable to BAT’s growth rates before FY22.


Games Workshop Group — Momentum continued into Q325

By Edison Investment Research

Games Workshop Group’s (GAW’s) trading update states core and licensing revenue in January and February 2025 have been better than expected, continuing the momentum in Q325 that was reported at the time of the H125 results. As a result, we increase our FY25 PBT estimate by c 9%, while leaving our FY26 estimate unchanged.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Sun Pharmaceutical Industries, Immix Biopharma Inc, VolitionRX , CareCloud , Cigna Group, Biomea Fusion and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • How Acquiring Checkpoint Therapeutics Inc Adds Value to Sun Pharma?
  • Immix Biopharma — NXC-201 receives FDA RMAT designation
  • VolitionRx — Building real-world Nu.Q NETs sepsis data
  • Basilea Pharmaceutica — Encouraging start to the year for Cresemba
  • CCLD: 4Q24 Earnings – High-Quality EPS Beat Turning the Page to Growth
  • CCLD: 4Q24 Earnings – High-Quality EPS Beat Turning the Page to Growth
  • CCLD: 4Q24 Earnings – High-Quality EPS Beat Turning the Page to Growth
  • Cigna Group: Strategic Growth & Capital Investments Driving Our Optimism!
  • CCLD: 4Q24 Earnings – High-Quality EPS Beat Turning the Page to Growth
  • Biomea Fusion — An innovative approach to diabetes and obesity


How Acquiring Checkpoint Therapeutics Inc Adds Value to Sun Pharma?

By Nimish Maheshwari

  • Sun Pharmaceutical Industries (SUNP IN) is set to acquire Checkpoint Therapeutics for $355 million, enhancing its onco-dermatology portfolio with UNLOXCYT™, an FDA-approved treatment.
  • This strategic move provides Sun Pharma with immediate access to the U.S. market and the potential for global expansion, especially in the PD-1 inhibitor space.
  • The acquisition promises revenue growth and synergistic opportunities, although regulatory approvals and successful integration are crucial for realizing its full potential.

Immix Biopharma — NXC-201 receives FDA RMAT designation

By Edison Investment Research

Immix Biopharma has been granted a Regenerative Medicine Advanced Therapy (RMAT) designation by the US Food and Drug Administration (FDA) for the company’s novel sterically optimized CAR-T treatment, NXC-201, which is being developed as a potential treatment for relapsed/refractory amyloid light chain amyloidosis (r/r ALA). The RMAT designation offers several operational and regulatory benefits, which could streamline the clinical development and subsequent approval process for NXC-201, for example by enabling frequent interactions with the FDA. We note that NXC-201 has already been awarded orphan drug designation by the FDA and the European Medicines Agency (EMA), reflecting a robust position in what could be key markets for the therapy. NXC-201 is currently being evaluated in the US-based NEXICART-2 trial, and the next update (expected in H125) may represent a near-term catalyst for Immix, in our view.


VolitionRx — Building real-world Nu.Q NETs sepsis data

By Edison Investment Research

Volition continues to build data demonstrating that the Nu.Q® NETs H3.1 diagnostic platform is a potential breakthrough tool in sepsis management. These efforts underpin Volition’s aim to advance Nu.Q NETs as a rapid, accessible and accurate diagnostic test to manage this potentially devastating condition. Sepsis (immune system triggered organ dysfunction) affects c 50 million people a year worldwide, and results in c 11 million deaths. Further, every hour of delayed treatment raises the mortality risk by c 8%. In this note we review Volition’s recent updates from the ESICM Annual Congress, where it provided evidence across data comprising more than 3,000 patients that its technology can quickly and reliably detect the patients most at risk of mortality, septic shock and organ failure. Improving the identification and tracking of at-risk patients should help improve treatment paradigms.


Basilea Pharmaceutica — Encouraging start to the year for Cresemba

By Edison Investment Research

Basilea Pharmaceutica has continued its strong momentum into 2025, announcing the receipt of a CHF1.2m milestone payment for Cresemba for the strategically important Japanese market. This marks the first commercial milestone payment from Japanese licensing partner, Asahi Kasei Pharma, and comes within two years of market launch (in March 2023), which we view as an indication of the favourable market uptake for the company’s lead anti-infective drug. We note that Japan and China are key markets for Cresemba (making up c 25% of the drug’s global potential) and have experienced strong demand for this category-leading treatment. We expect these markets to support Basilea in life cycle management for Cresemba as it approaches maturity in the primary US and European markets (loss of market exclusivity in Q427). Our estimates are under review ahead of the forthcoming FY24 results, due to be published on 18 February 2025.


CCLD: 4Q24 Earnings – High-Quality EPS Beat Turning the Page to Growth

By Zacks Small Cap Research

  • Key 4Q24 takeaways include: 1) we look for sustainable revenue/earnings growth reflecting powerful industry tailwinds and CCLD’s comprehensive suite of fully integrated services combined with targeted marketing initiatives 2) rising free cash flow continues to drive a real-time step up in capital deployment including the early resumption of preferred stock dividend payments and reinvesting in the business to accelerate growth and 3) we look for management to increasingly capitalize on M&A opportunities (see the recently announced acquisition of MesaBilling), particularly now that CCLD shareholders approved upsizing the company’s share authorization by 50 million shares, with the Board recently announcing the conversion of Series A Preferred Stock to common stock, thereby freeing up considerable capacity for deals, while generating meaningful savings related to lower preferred stock dividends.

CCLD: 4Q24 Earnings – High-Quality EPS Beat Turning the Page to Growth

By Zacks Small Cap Research

  • Key 4Q24 takeaways include: 1) we look for sustainable revenue/earnings growth reflecting powerful industry tailwinds and CCLD’s comprehensive suite of fully integrated services combined with targeted marketing initiatives 2) rising free cash flow continues to drive a real-time step up in capital deployment including the early resumption of preferred stock dividend payments and reinvesting in the business to accelerate growth and 3) we look for management to increasingly capitalize on M&A opportunities (see the recently announced acquisition of MesaBilling), particularly now that CCLD shareholders approved upsizing the company’s share authorization by 50 million shares, with the Board recently announcing the conversion of Series A Preferred Stock to common stock, thereby freeing up considerable capacity for deals, while generating meaningful savings related to lower preferred stock dividends.

CCLD: 4Q24 Earnings – High-Quality EPS Beat Turning the Page to Growth

By Zacks Small Cap Research

  • Key 4Q24 takeaways include: 1) we look for sustainable revenue/earnings growth reflecting powerful industry tailwinds and CCLD’s comprehensive suite of fully integrated services combined with targeted marketing initiatives 2) rising free cash flow continues to drive a real-time step up in capital deployment including the early resumption of preferred stock dividend payments and reinvesting in the business to accelerate growth and 3) we look for management to increasingly capitalize on M&A opportunities (see the recently announced acquisition of MesaBilling), particularly now that CCLD shareholders approved upsizing the company’s share authorization by 50 million shares, with the Board recently announcing the conversion of Series A Preferred Stock to common stock, thereby freeing up considerable capacity for deals, while generating meaningful savings related to lower preferred stock dividends.

Cigna Group: Strategic Growth & Capital Investments Driving Our Optimism!

By Baptista Research

  • The Cigna Group’s fourth-quarter and full-year 2024 financial results reflect a mixed performance, with certain aspects showing growth while others reveal challenges.
  • The company reported a full-year revenue increase of 27% to approximately $247 billion, highlighting strong revenue growth.
  • Adjusted earnings per share (EPS) rose by 9% to $27.33, although this was below expectations, indicating some pressure on profitability.

CCLD: 4Q24 Earnings – High-Quality EPS Beat Turning the Page to Growth

By Zacks Small Cap Research

  • Key 4Q24 takeaways include: 1) we look for sustainable revenue/earnings growth reflecting powerful industry tailwinds and CCLD’s comprehensive suite of fully integrated services combined with targeted marketing initiatives 2) rising free cash flow continues to drive a real-time step up in capital deployment including the early resumption of preferred stock dividend payments and reinvesting in the business to accelerate growth and 3) we look for management to increasingly capitalize on M&A opportunities (see the recently announced acquisition of MesaBilling), particularly now that CCLD shareholders approved upsizing the company’s share authorization by 50 million shares, with the Board recently announcing the conversion of Series A Preferred Stock to common stock, thereby freeing up considerable capacity for deals, while generating meaningful savings related to lower preferred stock dividends.

Biomea Fusion — An innovative approach to diabetes and obesity

By Edison Investment Research

Biomea Fusion is a clinical-stage biopharmaceutical company developing novel small molecules to cure metabolic diseases. Its proprietary FUSION System platform has created a pipeline of covalent candidates, which are drug molecules that form permanent bonds with their target proteins in the body, offering potential advantages over traditional non-covalent drugs. Lead asset icovamenib is in clinical trials for type 2 and type 1 diabetes (T2D; T1D), aiming to address critical unmet needs in the space. The company is also advancing next-generation asset BMF-650 towards the clinic, for diabetes and obesity. The treatment markets for these disease areas are projected to reach c $134bn and c $105bn, respectively, by 2030. Multiple pipeline catalysts are anticipated for Biomea throughout 2025.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: KRX Short Interest Weekly (Mar 7th): Kakao and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • KRX Short Interest Weekly (Mar 7th): Kakao, Hlb, Samsung Electronics


KRX Short Interest Weekly (Mar 7th): Kakao, Hlb, Samsung Electronics

By Ke Yan, CFA, FRM

  • We analyzed the changes in short interest of KRX stocks as of Mar 7th which has an aggregated short interest worth USD3.6bn.
  • We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
  • We highlight short interest changes in Kakao, Hlb, Samsung Electronics.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: Stock Splits Meet Many Companies’ Needs to Increase the Shareholdings of Individual Investors and more

By | Daily Briefs, ESG

In today’s briefing:

  • Stock Splits Meet Many Companies’ Needs to Increase the Shareholdings of Individual Investors


Stock Splits Meet Many Companies’ Needs to Increase the Shareholdings of Individual Investors

By Aki Matsumoto

  • The increase in stock splits can be attributed to TSE requesting more effective measures from companies after market restructuring and to more companies whose stock prices have risen.
  • Companies are obsessed with getting individual investors on their side. It seems that the interests of companies and TSE are aligned in conducting stock splits to increase individual investors’ shareholdings.
  • Now that many companies want to increase the number of individual investors, it may be a good time to resolve the cost issue and consider changing the share unit system.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars